The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
Open accessAbstract
Development of specific antivirals is an urgent unmet need for SARS-coronavirus 2 (SARS-CoV-2) infections. This study focuses on host proteases that proteolytically activate the SARS-CoV-2 spike protein, critical for its fusion activity after binding to ACE2 receptor, as antiviral targets. We first validated cleavage at a putative furin substrate motif at SARS-CoV-2 spike by expressing it in VeroE6 cells and found prominent syncytium formation. Both cleavage and syncytium were abolished by treatment with the furin inhibitors decanoyl-RVKR-chloromethylketone (CMK) and naphthofluorescein but not by the TMPRSS2 inhibitor camostat. CMK and naphthofluorescein showed antiviral effects in SARS-CoV-2-infected cells by decreasing viral production and cytopathic effects. Further analysis revealed that, similar to camostat, CMK blocks virus entry, but it further suppresses the cleavage of spike and syncytium. Naphthofluorescein instead acts primarily by suppressing viral RNA transcription after viral entry. Therefore, furin inhibitors may become promising antivirals for prevention and treatment of SARS-CoV-2 infections. Funding: This study was supported by grants from the Ministry of Science and Technology, Taiwan (106-2622-B-002-002-CC2, 107-3017-F-002-002) and the “Center of Precision Medicine” from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. Conflict of Interest: The authors declare no competing interests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Remacle, A. G., Gawlik, K., Golubkov, V. S., Cadwell, G. W., Liddington, R., Cieplak, P., Millis, S. Z., Desjardins, R., Routhier, S., Yuan, X. W., et al. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.013 · Cited by 44
RetractedHoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Self-citationZhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,073
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
Gurwitz, D. (2020) · Drug Development Research · doi:10.1002/ddr.21656 · Cited by 802
Structural insights into coronavirus entry
(2019) · Advances in Virus Research · doi:10.1016/bs.aivir.2019.08.002 · Cited by 769
The biology and therapeutic targeting of the proprotein convertases
Seidah, N. G., & Prat, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3699 · Cited by 759
Gaunt, E. R., Hardie, A., Claas, E. C. J., Simmonds, P., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 686
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Avoiding the void: Cell-to-cell spread of human viruses
Sattentau, Q. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1972 · Cited by 614
Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020) · Molecular Informatics · doi:10.1002/minf.202000028 · Cited by 517
Henrich, S., Cameron, A., Bourenkov, G. P., Kiefersauer, R., Huber, R., Lindberg, I., Bode, W., & Than, M. E. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb941 · Cited by 342
Furin‐mediated protein processing in infectious diseases and cancer
Braun, E., & Sauter, D. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1073 · Cited by 342
Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
Heald-Sargent, T., & Gallagher, T. (2012) · Viruses · doi:10.3390/v4040557 · Cited by 321
The activation and physiological functions of the proprotein convertases
Seidah, N. G., Mayer, G., Zaid, A., Rousselet, E., Nassoury, N., Poirier, S., Essalmani, R., & Prat, A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.030 · Cited by 314
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 307
Coleman, C. M., Sisk, J. M., Mingo, R. M., Nelson, E. A., White, J. M., & Frieman, M. B. (2016) · Journal of Virology · doi:10.1128/jvi.01429-16 · Cited by 257
Protease Inhibitors as Antiviral Agents
Patick, A. K., & Potts, K. E. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.614 · Cited by 221
Wu, C.-H., Chen, P.-J., & Yeh, S.-H. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.009 · Cited by 216
Self-citationFrana, M. F., Behnke, J. N., Sturman, L. S., & Holmes, K. V. (1985) · Journal of Virology · doi:10.1128/jvi.56.3.912-920.1985 · Cited by 213
Wu, C.-H., Yeh, S.-H., Tsay, Y.-G., Shieh, Y.-H., Kao, C.-L., Chen, Y.-S., Wang, S.-H., Kuo, T.-J., Chen, D.-S., & Chen, P.-J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805747200 · Cited by 190
Self-citationZeng, Z.-Q., Chen, D.-H., Tan, W.-P., Qiu, S.-Y., Xu, D., Liang, H.-X., Chen, M.-X., Li, X., Lin, Z.-S., Liu, W.-K., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3144-z · Cited by 169
The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases
Izaguirre, G. (2019) · Viruses · doi:10.3390/v11090837 · Cited by 164
Wang, Q., Qiu, Y., Li, J., Zhou, Z., Liao, C.-H., & Ge, X. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00212-7 · Cited by 138
Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool
Adalja, A. A., & Inglesby, T. V. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1635009 · Cited by 120
Becker, G. L., Sielaff, F., Than, M. E., Lindberg, I., Routhier, S., Day, R. W., Lu, Y., Garten, W., & Steinmetzer, T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9012455 · Cited by 117
Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins
Ou, X., Zheng, W., Shan, Y., Mu, Z., Dominguez, S. R., Holmes, K. V., & Qian, Z. (2016) · Journal of Virology · doi:10.1128/jvi.00015-16 · Cited by 116
Is hydroxychloroquine beneficial for COVID-19 patients?
Li, X., Wang, Y., Agostinis, P., Rabson, A. B., Melino, G., Carafoli, E., Shi, Y., & Sun, E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2721-8 · Cited by 112
Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_4 · Cited by 104
A Small-Molecule Furin Inhibitor Inhibits Cancer Cell Motility and Invasiveness
Coppola, J. M., Bhojani, M. S., Ross, B. D., & Rehemtulla, A. (2008) · Neoplasia · doi:10.1593/neo.08166 · Cited by 101
Anti-HSV activity of digitoxin and its possible mechanisms
Su, C.-T., Hsu, J. T.-A., Hsieh, H., Lin, P., Chen, T.-C., Kao, C., Lee, C., & Chang, S. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.156 · Cited by 88
Self-citationWatanabe, R., Matsuyama, S., Shirato, K., Maejima, M., Fukushi, S., Morikawa, S., & Taguchi, F. (2008) · Journal of Virology · doi:10.1128/jvi.01412-08 · Cited by 88
Sarač, M. S., Cameron, A., & Lindberg, I. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.7136-7139.2002 · Cited by 85
The direct passage of animal viruses between cells
Sattentau, Q. J. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.09.004 · Cited by 72
Nakagaki, K., Nakagaki, K., & Taguchi, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6102-6110.2005 · Cited by 55
Yamada, Y., Liu, X. B., Fang, S. G., Tay, F. P., & Liu, D. X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006130 · Cited by 50
Activation of Viruses by Host Proteases
Friebertshäuser, E., Garten, W., & Klenk, H. (2019) · Cambridge International Law Journal · doi:10.1007/978-3-319-75474-1 · Cited by 49
Imran, M., Saleemi, M. K., Chen, Z., Wang, X., Zhou, D., Li, Y., Zhao, Z., Zheng, B., Li, Q., Cao, S., et al. (2019) · Viruses · doi:10.3390/v11111011 · Cited by 42
Coppola, J. M., Hamilton, C. A., Bhojani, M. S., Larsen, M. J., Ross, B. D., & Rehemtulla, A. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.01.013 · Cited by 38
Croissandeau, G., Basak, A., Seidah, N. G., et al. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1203 · Cited by 21
Cited by
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Structural biology of SARS-CoV-2: open the door for novel therapies
Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 291
Furin cleavage sites naturally occur in coronaviruses
Wu, Y., & Zhao, S. (2021) · Stem Cell Research · doi:10.1016/j.scr.2020.102115 · Cited by 117
Pharmacological features, health benefits and clinical implications of honokiol
Khatoon, F., Ali, S., Kumar, V., Elasbali, A. M., Alhassan, H. H., Alharethi, S. H., Islam, A., & Hassan, M. I. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2120541 · Cited by 50
Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites
Liu, X., Wu, Q., & Zhang, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649314 · Cited by 32
Metadata
- Authors
- Cheng, Y.-W., Chao, T.-L., Li, C.-L., Chiu, M.-F., Kao, H.-C., Wang, S.-H., Pang, Y.-H., Lin, C.-H., Tsai, Y.-M., Lee, W.-H., Tao, M.-H., Ho, T.-C., Wu, P.-Y., Jang, L.-T., Chen, P.-J., Chang, S.-Y., & Yeh, S.-H.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 33
- Issue
- 2
- Pages
- 108254
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W3040035440
- Cited by
- 257
- References
- 51
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.